2 For patients with symptomatic telangiectasias
or reticular veins we suggest transcutaneous laser
treatment if the patient has sclerosant allergy, needle
phobia, sclerotherapy failure or small veins (<1 mm)
with telangiectatic matting.
GUIDELINE. Grade of recommendation 2 (weak),
Quality of Evidence B (moderate)
Rationale and evidence. Surface lasers used to treat
telangiectasias have wavelength between 53